ATE170853T1 - Antitumorpräparate und verfahren zur behandlung - Google Patents

Antitumorpräparate und verfahren zur behandlung

Info

Publication number
ATE170853T1
ATE170853T1 AT93300710T AT93300710T ATE170853T1 AT E170853 T1 ATE170853 T1 AT E170853T1 AT 93300710 T AT93300710 T AT 93300710T AT 93300710 T AT93300710 T AT 93300710T AT E170853 T1 ATE170853 T1 AT E170853T1
Authority
AT
Austria
Prior art keywords
treatment
methods
antitumor preparations
antitumor
preparations
Prior art date
Application number
AT93300710T
Other languages
English (en)
Inventor
George Bernard Boder
William Joseph Ehlhardt
Gerald Burr Grindey
John Eldon Toth
John Frederick Worzalla
John Lyle Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE170853T1 publication Critical patent/ATE170853T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
AT93300710T 1992-02-05 1993-02-01 Antitumorpräparate und verfahren zur behandlung ATE170853T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/831,604 US5254582A (en) 1992-02-05 1992-02-05 Antitumor compositions and methods

Publications (1)

Publication Number Publication Date
ATE170853T1 true ATE170853T1 (de) 1998-09-15

Family

ID=25259448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93300710T ATE170853T1 (de) 1992-02-05 1993-02-01 Antitumorpräparate und verfahren zur behandlung

Country Status (25)

Country Link
US (1) US5254582A (de)
EP (1) EP0555036B1 (de)
JP (1) JP3210117B2 (de)
KR (1) KR100246148B1 (de)
CN (1) CN1044239C (de)
AT (1) ATE170853T1 (de)
AU (1) AU658043B2 (de)
BR (1) BR9300469A (de)
CA (1) CA2088719A1 (de)
CY (1) CY2101B1 (de)
CZ (1) CZ282753B6 (de)
DE (1) DE69320844T2 (de)
DK (1) DK0555036T3 (de)
ES (1) ES2121940T3 (de)
FI (1) FI930453L (de)
HU (2) HU213231B (de)
IL (1) IL104574A (de)
MX (1) MX9300558A (de)
MY (1) MY109640A (de)
NO (1) NO302472B1 (de)
NZ (1) NZ245818A (de)
RU (1) RU2072996C1 (de)
SG (1) SG79181A1 (de)
YU (1) YU48915B (de)
ZA (1) ZA93689B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
AU709107B2 (en) * 1996-08-22 1999-08-19 Dong Wha Pharmaceutical Industrial Co., Ltd. Arylsulfonylimidazolone derivatives as an antitumor agent
EP0929540A4 (de) * 1996-10-04 2001-12-12 Lilly Co Eli Antitumor-zusamensetzungen und behandlungsverfahren
US6281240B1 (en) * 1997-04-10 2001-08-28 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
US5932407A (en) * 1997-04-30 1999-08-03 Eastman Kodak Company Color photographic element containing oxidized developer-scavenging naphtholic coupler forming wash-out dye
EP1663978B1 (de) 2003-07-23 2007-11-28 Bayer Pharmaceuticals Corporation Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
WO2006030947A1 (ja) * 2004-09-13 2006-03-23 Eisai R & D Management Co., Ltd. スルホンアミド含有化合物の血管新生阻害物質との併用
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
US20100291592A1 (en) 2006-04-20 2010-11-18 Taro Semba Novel marker for sensitivity against sulfonamide compound
CN104941647B (zh) * 2015-06-18 2017-07-04 四川之江高新材料股份有限公司 合成n‑甲基吗啉的方法及所用的负载型催化剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083207A (en) * 1963-03-26 Indolinesulfonylureas
US1208561A (en) * 1914-09-14 1916-12-12 Stephen E Huff Sound-box attachment for phonographs.
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
US3102121A (en) * 1961-06-29 1963-08-27 Olin Mathieson Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas
BE634577A (de) * 1962-04-11
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
IL69621A0 (en) * 1982-09-02 1983-12-30 Duphar Int Res Pharmaceutical compositions having antitumor activity,comprising certain phenylurea derivatives
CA1208561A (en) * 1984-01-19 1986-07-29 Marius S. Brouwer Pharmaceutical compositions containing benzoylurea compounds
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
JPS6163671A (ja) * 1984-09-05 1986-04-01 Shionogi & Co Ltd ２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
NZ238911A (en) * 1990-07-17 1993-10-26 Lilly Co Eli Furyl, pyrrolyl and thienyl sulphonyl urea derivatives, pharmaceutical compositions and intermediates therefor
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
CN1075961A (zh) 1993-09-08
NO930380D0 (no) 1993-02-03
YU48915B (sh) 2002-11-15
DK0555036T3 (da) 1999-06-07
FI930453A7 (fi) 1993-08-06
EP0555036B1 (de) 1998-09-09
YU5893A (sh) 1996-07-24
DE69320844D1 (de) 1998-10-15
AU658043B2 (en) 1995-03-30
RU2072996C1 (ru) 1997-02-10
MY109640A (en) 1997-03-31
KR100246148B1 (ko) 2000-04-01
KR930017885A (ko) 1993-09-20
CN1044239C (zh) 1999-07-21
CA2088719A1 (en) 1993-08-06
NZ245818A (en) 1995-03-28
BR9300469A (pt) 1993-08-10
ZA93689B (en) 1994-08-01
CY2101B1 (en) 2002-04-05
HUT63842A (en) 1993-10-28
HU211561A9 (en) 1995-12-28
CZ12093A3 (en) 1993-12-15
AU3218393A (en) 1993-08-12
US5254582A (en) 1993-10-19
NO930380L (no) 1993-08-06
MX9300558A (es) 1993-08-01
ES2121940T3 (es) 1998-12-16
EP0555036A2 (de) 1993-08-11
HU9300288D0 (en) 1993-04-28
FI930453A0 (fi) 1993-02-02
IL104574A (en) 1997-02-18
FI930453L (fi) 1993-08-06
JPH05306277A (ja) 1993-11-19
IL104574A0 (en) 1993-06-10
CZ282753B6 (cs) 1997-09-17
DE69320844T2 (de) 1999-03-04
HU213231B (en) 1997-03-28
EP0555036A3 (en) 1993-11-24
JP3210117B2 (ja) 2001-09-17
SG79181A1 (en) 2001-03-20
NO302472B1 (no) 1998-03-09

Similar Documents

Publication Publication Date Title
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
NO304884B1 (no) 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
EP0758843A4 (de) Modifizierte aminosäuren zur verabreichung von medikamenten
GEP20032995B (en) 1-Amino-Alkylcyclohexane NMDA Receptor Antagonists
TR199901132T2 (xx) N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler.
DE69320844D1 (de) Antitumorpräparate und Verfahren zur Behandlung
PH31655A (en) Tripeptide antitihrombotic agents.
FR2740134B1 (fr) Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant
UA42719C2 (uk) Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
RU93004535A (ru) Соединения, способ получения и фармацевтическая композиция на их основе
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
AP9901472A0 (en) Crystalline pharmaceutical product.
DE69840432D1 (de) Arzneimittel zur behandlung der augen
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения
DE69327074D1 (de) Substituierte 1,2,4-Triazine-3,5-Dion Derivate und diese enthaltende Arzneimittel, insbesondere zur Behandlung von Coccidiose
EP0579765A4 (en) Method and composition for the treatment of herpes related disorders
TH9193B (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
EP0671935A4 (de) Aminsäurekonjugate von amin-cyclohexapeptiden.
IT1248835B (it) Procedimento e apparecchiatura per la preparazione di nylon-6 da e-caprolattame con trattamento con ultrasuoni
TH13149A (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
IT1282951B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento dell'insonnia
ITMI951410A0 (it) Utilizzo di sequenze di endorfina per la preparazione di un medicamento immunosoppressore privo di attivita' oppiacea
UA29449C2 (uk) N-заміщені похідні 3-азабіцикло[3.2.0]гептану

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee